XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Income Taxes
6 Months Ended
Jun. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
For the three month period ended June 30, 2019, the Company recorded a provision for income taxes of $5,851 (effective tax rate of 38.7 percent) compared to $2,267 (effective tax rate of 12.6 percent) for the same period in 2018. For the six month period ended June 30, 2019, the Company recorded a provision for income taxes of $12,186 (effective tax rate of 42.6 percent) compared to $5,718 (effective tax rate of 18.8 percent) for the same period in 2018. The 2019 and 2018 three and six month period provisions for income taxes are calculated using a forecasted multi-jurisdictional annual effective tax rate to determine a blended annual effective tax rate. The effective tax rate for the three and six month periods ended June 30, 2019 differs from the U.S. federal statutory rate of 21 percent primarily due to net discrete tax expense of $1,968 and $4,385 recorded during the three and six month periods, respectively, as well as due to the projected mix of earnings in international jurisdictions with differing tax rates and jurisdictions where valuation allowances are recorded. The discrete tax items in the second quarter primarily consist of state reserves for additional uncertain tax positions of $4,710 partially offset by expected refunds and deferred tax benefits related to other state filings of $2,958. For the six month period ended June 30, 2019, the discrete items also include 2017 transition tax and unrecognized tax benefits accrued of $1,655 and $670, respectively, as a result of final U.S. federal tax guidance issued during the first quarter pertaining to the one-time mandatory deemed repatriation under the 2017 Tax Act.
The Company continues to maintain valuation allowances pursuant to ASC 740, “Accounting for Income Taxes,” against portions of its U.S. and non-U.S. deferred tax assets at June 30, 2019 as it cannot assure the future realization of the associated tax benefits prior to their reversal or expiration. In the U.S., the Company has offset a portion of its deferred tax asset relating primarily to a loss carryforward by a valuation allowance of $1,402. In addition, the Company has recorded valuation allowances of $23,065 relating to non-U.S. net operating losses and other deferred tax assets for a total valuation allowance of $24,467. In conjunction with the Company’s ongoing review of its actual results and anticipated future earnings, the Company will continue to reassess the possibility of releasing all or part of the valuation allowances currently in place when the associated deferred tax assets are deemed to be realizable.

The Company maintains an ASC 740-10, “Accounting for Uncertainty in Income Taxes,” liability for unrecognized tax benefits. At June 30, 2019, the Company’s liability, exclusive of penalty and interest, totals approximately $11,663. The Company accrued an additional $5,138 for gross unrecognized tax benefits and $946 of interest expense during the six month
period ended June 30, 2019. Based upon the outcome of tax examinations, judicial proceedings, or expiration of statutes of limitations, it is possible that the ultimate resolution of the Company's unrecognized tax benefits may result in a payment that is materially different from the current estimate of the tax liabilities.
The Company operates in multiple jurisdictions throughout the world. The Company has effectively settled U.S. federal tax examinations for tax years before 2015 and state and local examinations for tax years before 2013, with limited exceptions. Furthermore, the Company’s non-U.S. subsidiaries are generally no longer subject to income tax examinations in major foreign taxing jurisdictions for tax years prior to 2015. Certain of the Company's state income tax returns in various jurisdictions are currently under examination and it is possible that these examinations will conclude within the next twelve months. However, it is not possible to estimate net increases or decreases in the Company’s unrecognized tax benefits during the next twelve months.